Atossa Therapeutics announced enrollment and dosing completed in clinical study of AT-301 COVID-19 nasal spray
On Aug. 17, 2020, Atossa Therapeutics announced that it had enrolled and dosed the first cohort of healthy…
On Aug. 17, 2020, Atossa Therapeutics announced that it had enrolled and dosed the first cohort of healthy…
On Aug. 17, 2020, the USDA National Veterinary Services Laboratories (NVSL) announced the first confirmed cases of SARS-CoV-2…
On Aug. 17, 2020, PerkinElmer announced the launch of a series of explorerï¾™ workstations for SARS-CoV-2 testing capable…
On Aug. 17, 2020, Novavax announced the beginning of a Phase 2b clinical trial in South Africa to…
On Aug. 17, 2020, XBiotech announced that it had identified True Human antibodies that could potentially be used…
On Aug. 15, 2020, the FDA issued an emergency use authorization (EUA) to Yale School of Public Health…
On Aug. 14, 2020, AstraZeneca concluded an agreement with the European Commission (EC) to supply up to 400…
On Aug. 14, 2020, Medigen Vaccine Biologics (MBV) published preclinical results of their COVID-19 vaccine candidate in BioRxiv,…
On Aug. 14, 2020, Novavax announced it had signed a Heads of Terms (Term Sheet) with the Government…
On Aug. 13, 2020, data from the WHO/UNICEF Joint Monitoring Programme (JMP) revealed that 43 per cent of…
On Aug. 13, 2020, Royal Philips introduced its Rapid Equipment Deployment Kit for ICU ramp-ups, allowing doctors, nurses,…
On Aug. 13, 2020, Dynavax Technologies announced a grant from the Bill & Melinda Gates Foundation of $3.4…
On Aug. 13, 2020, Novavax and SK bioscience announced a development and supply agreement for the antigen component…
On Aug. 13, 2020, Heat Biologics reported preclinical data for Heat’s gp96-based COVID-19. The data, generated at the…
On Aug. 13, 2020, the U.S. Department of Health and Human Services (HHS) announced combined investments of $6.5…
On Aug. 12, 2020, Baxter announced it had received Emergency Use Authorizations (EUAs) from the FDA for the…
On Aug. 12, 2020, Thermo Fisher Scientific announced it had committed to supporting the efforts of historically black…
On Aug. 12, 2020, Celdara Medical announced that the NIH had awarded a Small Business Innovation Research (SBIR)…
On Aug. 11, 2020, Hologic announced that it has validated use of its Aptimaï¾® and Panther Fusionï¾® molecular…
On Aug. 11, 2020, LabCorpï¾® announced details of a no charge antibody testing program in response to federal…
On Aug. 10, 2020, Gilead Sciences announced that it had submitted a New Drug Application (NDA) to the…
On Aug. 10, 2020, Vaxart announced that its COVID-19 Investigational New Drug (IND) application has been filed with…
On Aug. 10, 2020, CBRï¾® by Generate Life Sciences, the worldï¾’s largest private newborn stem cell bank, and…
On Aug. 10, 2020, Humanigen announced that the Brazilian regulatory agency, Anvisa, had granted permission to commence a…
On Aug. 10, 2020, Omeros reported the results of a compassionate-use study evaluating narsoplimab, Omerosï¾’ investigational human monoclonal…
On Aug. 9, 2020, OpGen announced that it had commenced marketing and promotion, on a non-exclusive basis, of…
On Aug. 7, 2020, scientists at Scripps Research announced they had obtained high-resolution, atomic-scale details of the structure…
On Aug. 7, 2020, Novavax and Takeda Pharmaceutical announced a partnership for the development, manufacturing and commercialization of…
On Aug. 7, 2020, Pfizer announced a multi-year agreement with Gilead Sciences to manufacture and supply Gileadï¾’s investigational…
On Aug. 6, 2020, RedHill Biopharma announced approval from the Mexican Federal Committee for the Protection against Sanitary…